Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

SHE:300584 Revenue

Nanjing Hicin Pharmaceutical had revenue of 160.34M CNY in the quarter ending March 31, 2026, with 12.40% growth. This brings the company's revenue in the last twelve months to 688.74M, up 26.97% year-over-year. In the year 2025, Nanjing Hicin Pharmaceutical had annual revenue of 671.05M with 33.05% growth.

• Revenue (ttm): 688.74M
• Revenue Growth: +26.97%
• P/S Ratio: 7.55
• Revenue / Employee: 1.26M
• Employees: 548
• Market Cap: 5.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	671.05M	166.69M	33.05%
Dec 31, 2024	504.36M	-13.47M	-2.60%
Dec 31, 2023	517.83M	-8.63M	-1.64%
Jan 1, 2023	526.47M	-51.85M	-8.97%
Jan 1, 2022	578.32M	-127.98M	-18.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error